NEWS
Kalbe Farma team successfully completed the comprehensive Radiopharmacy training provided by Medicheck.
GE HealthCare's guests from PT Kalbe Farma Tbk team who will soon be operating Kalbe's first radiopharmaceutical facility in Jakarta received a comprehensive Radiopharmacy training at the Medicheck premises in Istanbul. We are proud to be part of Kalbe's contribution towards health independence in Indonesia and its commitment to continue to improve access to healthcare. We wish the whole team success in their operations.
More
Certificates were given to the participants in the "Radiopharmacy Immersion" training provided by Medicheck.
GE HealthCare guests from Iraq successfully completed the "Radiopharmacy Immersion" training held at Medicheck facility in İstanbul between 13-17 November 2023 and received their certificates. Medicheck wishes success to the participants in their radiopharmacy operations.
More
We participated the 15th National Parkinson's Disease and Movement Disorders Congress with GE HealthCare.
Together with GE HealthCare, we participated in the 15th National Parkinson's Disease and Movement Disorders Congress held in Hilton Dalaman Sarıgerme between 15-19 March 2023 as a sponsor. We had the chance to exchange ideas and make mutual discussions in productive meetings with our esteemed physicians, one of the important stakeholders of the sector, and members of the Turkish Parkinson's Disease Association, representing patients’ relatives..
More
We participated the 35th National Nuclear Medicine Congress.
We attended the 35th National Nuclear Medicine Congress held in Titanic Congress Center - Belek, Antalya between 26-30 April 2023 and had the opportunity to meet our esteemed physicians and industry partners.
More
Medicheck Hosted GE Healthcare's Training
Medicheck Silivri facility hosted the "PETtrace 800 series Service Training L1" training organized by GE Healthcare between 08-19 December 2022, with the participation of Medicheck engineers as well as international participants.
More
Medicheck attended the 34th National Nuclear Medicine Congress
Participated in the 34th National Nuclear Medicine Congress held at Antalya Kaya Palazzo Congress Center as a silver sponsor.
MoreDaTSCAN and Vizamyl products were launched in Turkey at the 55th National Neurology Congress
At the 55th National Neurology Congress with the Main Theme of “Movement Disorders”, with The Satellite Symposium titled "Parkinson or Alzheimer's? A New Dimension in Neuroimaging", which Chaired by Prof. Dr. Murat Emre and Prof.Dr. Jakub Hort, Prof.Dr. Paolo Barone were speakers, was held under the sponsorship of GE Healthcare and Medicheck, the Turkish launch of DaTSCAN and Vizamyl products was held at Antalya Maritim Pine Beach Hotel with high participation and interest.
More
Amyloid PET imaging agent VIZAMYL is in Turkey with domestic production
Granted to high priority licensing process by TITCK, with the completion of the licensing process of our product, Vizamyl® (18F-Flutemetamol), Turkey has become one of the few countries where Amyloid PET can be scanned.
More
Sharing Medicheck experience
The Medicheck team shared their experience on the PETTrace 890 model update with international participants at the GE Healthcare User Forum event in Saint Petersburg, Russia, upon invitation.
MoreThe world's first PETTrace 890 model update was performed at Medicheck
Within the framework of the pilot plant agreement signed with GE Healthcare, the process of updating the world's first PETTrace 890 model was successfully completed on Medicheck cyclotrons as a result of the joint work of GE Healthcare and Medicheck team.
MoreDaTSPECT imaging agent DaTSCAN is in Turkey
Our product, named DaTSCAN® (I123-Ioflupan), which was added to the foreign drug list in July 2014 and brought to Turkey as a bedside via the Turkish Pharmacists' Association, was licensed by TITCK and the long supply time was no longer a problem.
More